1. Signaling Pathways
  2. Cytoskeleton
  3. Integrin
  4. α4β7 Isoform
  5. α4β7 Antagonist

α4β7 Antagonist

α4β7 Antagonists (4):

Cat. No. Product Name Effect Purity
  • HY-14951
    Antagonist 99.62%
    Firategrast (SB 683699) is an orally active and specific α4β1/α4β7 integrin antagonist. Firategrast reduces trafficking of lymphocytes into the central nervous system (CNS) and decreases multiple sclerosis (MS) activity.
  • HY-15770
    Antagonist 98.06%
    TR-14035 is a orally active dual α4β74β1 integrin antagonist, with IC50 s of 7 nM and 87 nM for α4β7 and α4β1, respectively. TR-14035 can be used for the research of inflammation and autoimmune diseases.
  • HY-138542
    Antagonist 98.69%
    RO0270608, the active metabolite of R411, is a dual alpha4beta1-alpha4beta7 (α4β1/α4β7) integrin antagonist. Antiinflammatory activity.
  • HY-14189
    Valategrast hydrochloride
    Valategrast hydrochloride (R-411) is a potent integrin α4β1 (VLA-4) and α4β7 dual antagonist. Valategrast hydrochloride has the potential for Chronic obstructive pulmonary disease (COPD) and asthma treatment.